Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics.

David Langton,John Politis,Taya Collyer,Su-Wei Khung,Philip Bardin

Respirology (Carlton, Vic.)（2023）

引用 1|浏览1

暂无评分

摘要

In this large group of severe eosinophilic asthmatics, mepolizumab and benralizumab both improved disease parameters. However, benralizumab treatment appeared significantly more effective than mepolizumab in reducing exacerbations, improving FEV and depleting blood eosinophils.

查看译文

关键词

asthma, benralizumab, eosinophil, mepolizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要